SavedAdd your journal

Journals / Marmara Medical Journal / 2026 / Volume: 20 Issue: 2

-

LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ

Esra Saatçi
Yüksel Koçak
Nafiz Bozdemir
Ersin Akpınar
Zeynep Kalaylıoğlu-wheeler
Pages
—
Publication Date
2015-06-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

-

Özet

Amaç: Kemoterapideki gelişmeler lenfomalı hastaların yaşam sürelerini önemli derecede uzatmıştır ve önemli sayıda hasta tedavi edilebilmektedir. Kemoterapi alan hastaların yaşam kalitelerinin değerlendirilmesi giderek daha fazla ilgi çeken bir konu olmuştur. Çalışmamızın amacı, lenfomalı hastalarda kemoterapinin yaşam kalitesine etkilerini değerlendirmektir. Gereç ve Yöntem: Haziran 2000-Ocak 2001 tarihleri arasında Çukurova Üniversitesi Tıp Fakültesi Onkoloji Bilim Dalı’nda Evre I lenfoma tanısı alan 49 hastaya kemoterapi öncesinde ve 2. kür sonrasında yaşam kalitesi anketi (EORTC QLQ C-30) uygulandı. Bulgular: Fiziksel aktivitelerin bazılarında, duygusal fonksiyonlar, ağrı ve halsizlik, dispne, iştahsızlık, uyku ve global yaşam kalitesinde tedavi sırasında anlamlı iyileşme saptandı. Kemoterapi, yaş, cinsiyet ve lenfoma tipi göz önüne alındığında, global yaşam kalitesini etkileyen en önemli faktör hastanın eğitim durumuydu. Sonuç: Çalışmamızın sonuçları, kemoterapi öncesindeki yaşam kalitesine kıyasla tedavi sonrası yaşam kalitesinde iyileşme olması nedeniyle, kemoterapi alma konusunda isteksiz olan hastalara yardımcı olmada kullanılabilir. Anahtar Kelimeler: Lenfoma, Yaşam kalitesi, EORTC QLQ C-30, Adana

🔖

Cite This Article

Saatçi, E., Koçak, Y., Bozdemir, N., Akpınar, E., Kalaylıoğlu-wheeler, Z. (2015). -. Marmara Medical Journal, Volume: 20 Issue: 2. https://ajindex.com/articles/1287139

References (95)

  1. Guyatt G, Veldhuyzen Van Zanten S, Feeny D, Patrick
  2. D. Measuring quality of life in clinical trials: a taxonomy
  3. and review. Can Med Assoc J 1989; 140: 1441-1448.
  4. Lauper P, Versteegen U. The importance of quality of
  5. life in policy decisions: new end points in medical
  6. outcome assessment. Pharm Med 1992; 5: 43-50.
  7. Schumacher A, Kessler T, Riedel A, Buchner T, van de
  8. Loo J. Quality of life and coping with illness in patients
  9. with acute myeloid leukemia. Psychother Psychosom
  10. Med Psychol 1996; 46: 385-390.
  11. Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S,
  12. Cavallin-Stahl E. Health-related quality of life and its
  13. potential prognostic implications in patients with
  14. aggressive lymphoma: a Nordic Lymphoma Group Trial.
  15. Medical Oncology 2001; 18: 85-94.
  16. Persson L, Larsson G, Ohlsson O, Hallberg IR. Acute
  17. leukemia or highly malignant lymphoma patients’
  18. quality of life over two years: a pilot study. Eur J of
  19. Cancer Care 2001; 10: 36-47.
  20. Cella DF, Tulsky S. Measuring quality of life today:
  21. methodological aspects. Oncology 1990; 4: 29-38.
  22. The WHOQOL Group. The World Health Organization
  23. quality of life assessment (WHOQOL): position paper
  24. from the World Health Organization. Soc Sci Med 1995;: 1403-1409.
  25. Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson
  26. BD. Quality-of-life assessment in cancer treatment
  27. protocols: research issues in protocol development. J
  28. Natl Cancer Inst 1992; 84: 575-579.
  29. Cella DF. Quality of life: the concept. J Palliat Care; 8: 8-13.
  30. Kaasa S, Loge JH. Quality of life in palliative care:
  31. principles and practice. Palliat Med 2003; 17: 11-20.
  32. Wierzbicka M, Kusnierkiewicz M, Wojtowicz JG,
  33. Maune S, Szyfter W. The quality of life in head and neck
  34. cancer patients: description of randomized examination
  35. formula based on standardized questionnaires EORTC
  36. QLQ C-30, EORTC QTQ-H-N35 and Kiel
  37. Questionnaire. Otolaryngol Pol 2001; 55: 287-292 [in
  38. Polish].
  39. Kaasa S, Bjordal K, Aaronson N, et al. The EORTC
  40. core quality of life questionnaire (QLQ-C30): validity
  41. and reliability when analyzed with patients treated with
  42. palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-
  43. Kobayashi K, Takeda F, Teramukai S, et al. A crossvalidation
  44. of the European Organization for Research
  45. and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)
  46. for Japanese with lung cancer. Eur J Cancer 1998; 34:
  47. Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A.
  48. Modification of the EORTC QLQ-C30 (version 2.0)
  49. based on content validity and reliability testing in large
  50. samples of patients with cancer. The Study Group on
  51. Quality of Life of the EORTC and the Symptom Control
  52. and Quality of Life Committees of the NCI of Canada
  53. Clinical Trials Group. Qual Life Res 1997; 6: 103-108.
  54. Aaronson NK, Ahmedzai S, Bergman B, et al. The
  55. European Organization for Research and Treatment of
  56. Cancer QLQ-C30: a quality-of-life instrument for use in
  57. international clinical trials in oncology. J Natl Cancer
  58. Inst 1993; 85: 365-376.
  59. Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.
  60. Development of a European Organization for Research
  61. and Treatment of Cancer (EORTC) questionnaire
  62. module to be used in quality of life assessments in head
  63. and neck cancer patients. EORTC Quality of Life Study
  64. Group. Acta Oncol 1994; 33: 879-885.
  65. Bjordal K, de Graeff A, Fayers PM, et al. A 12 country
  66. field study of the EORTC QLQ-C30 (version 3.0) and
  67. the head and neck cancer specific module (EORTC
  68. QLQ-H&N35) in head and neck patients. EORTC
  69. Quality of Life Group. Eur J Cancer 2000; 36: 1796-
  70. Blazeby JM, Alderson D, Winstone K, et al.
  71. Development of an EORTC questionnaire module to be
  72. used in quality of life assessment for patients with
  73. oesophageal cancer. The EORTC Quality of Life Study
  74. Group. Eur J Cancer 1996; 32A: 1912-1917.
  75. Sprangers MA, Cull A, Groenvold M, Bjordal K,
  76. Blazeby J, Aaronson NK. The European Organization
  77. for Research and Treatment of Cancer approach to
  78. developing questionnaire modules: an update and
  79. overview. EORTC Quality of Life Study Group. Qual
  80. Life Res 1998; 7: 291-300.
  81. Schumacher A, Kessler T, Buchner T, Wewers D, van
  82. de Loo J. Quality of life in adult patients with acute
  83. myeloid leukemia receiving intensive and prolonged
  84. chemotherapy-a longitudinal study. Leukemia 1998; 12:
  85. Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in longterm
  86. survivors of Hodgkin‘s lymphoma; a report from
  87. the German Hodgkin Lymphoma Study Group (GHSG).
  88. Eur J Cancer 2003; 39: 2179-2186.
  89. Vogelzang NJ, Breitbart W, Cella D, et al. Patient,
  90. caregiver, and oncologist perceptions of cancer-related
  91. fatigue: results of a tripart assessment survey. The
  92. Fatigue Coalition. Semin Hematol 1997; 34: 4-12.
  93. Curt GA. The impact of fatigue on patients with cancer:
  94. overview of FATIGUE 1 and 2. Oncologist 2000; 5
  95. (Suppl 2): 9-12.